IDS was established in 1968 and is one of the leading pharmaceutical and consumer healthcare product distributors in the region.

Our mission is to build partnerships of shared success and relationships of mutual appreciation with a collaborative network of pharmaceutical suppliers within the region, while keeping the customer’s interests first. We connect organizations and people through timely deliveries, a well-established network, competitive pricing and customized solutions to meet the distribution and support needs of manufacturers and healthcare providers.

During the last ten years, IDS has shown pronounced growth in every category including growing yearly revenues, market share, number of prescriptions, product portfolio, and representing international partners. Our product portfolio falls under different Therapeutic Classes, such as, Antibacterial, Asthma, Hypertension, Diabetes, Cardiovascular, Muscle Relaxant, Anticoagulant, Anti-rheumatic, Erectile Dysfunction and other classes.

More than 90% of our launches are successful and our partners’ sales and presence are growing year over year.

With a turnover exceeding AED 270 million in 2014, the distribution side of the business is going from strength to strength, with a minimum annual growth of 15% and a progressive annual sales growth in our consumer portfolio of 25% over the past 4 years.

IDS is in a strong financial position, and the double-digit growth witnessed over the last decade is expected to continue well into the future.

Our long term strategy is the launch of Pharmax, a state-of-the-art manufacturing facility used as primary packaging, secondary re-packaging and manufacturing from API. The custom built facility will produce high quality affordable healthcare and pharmaceutical products essential to a healthier and happier lifestyle.